This study is in progress, not accepting new patients
Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- VectivBio AG
- ID
- NCT05018286
- Phase
- Phase 3 Short Bowel Syndrome Research Study
- Study Type
- Interventional
- Participants
- About 158 people participating
- Last Updated